SCHEMBL18009302

SCHEMBL18009302

CC(C)OC(=O)/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)OC(C)C)N(C(=O)c2ccccc2)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.44
▸ TSHR P16473 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MMP2 P08253 1/20 0.35
▸ HCAR2 Q8TDS4 2/20 0.35
▸ HTR3E A5X5Y0 1/20 0.34
▸ HTR3B O95264 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ HTR3A P46098 1/20 0.34
▸ HTR3D Q70Z44 1/20 0.34
▸ HTR3C Q8WXA8 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ PLAU P00749 1/20 0.34
▸ ELANE P08246 1/20 0.34
▸ ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009300 0.94 PIK3CD (0.42) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18009294 0.83 MMP2 (0.46) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18007434 0.81 HCAR2 (0.38) MMP2HCAR2
SCHEMBL18009297 0.80 MAPT (0.40) PIK3CDSMN1; SMN2
SCHEMBL18009292 0.80 PIK3CD (0.41) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL27979463 0.80 PIK3CD (0.50) PIK3CDTSHRRECQLSMN1; SMN2CHRNA7
SCHEMBL18009283 0.79 ALDH1A1 (0.40) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18009461 0.78 PIK3CD (0.40) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18007451 0.76 PIK3CD (0.39) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18009337 0.75 MMP2 (0.42) MMP2HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback